JP2021500874A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021500874A5 JP2021500874A5 JP2020519382A JP2020519382A JP2021500874A5 JP 2021500874 A5 JP2021500874 A5 JP 2021500874A5 JP 2020519382 A JP2020519382 A JP 2020519382A JP 2020519382 A JP2020519382 A JP 2020519382A JP 2021500874 A5 JP2021500874 A5 JP 2021500874A5
- Authority
- JP
- Japan
- Prior art keywords
- specific binding
- binding molecule
- fragment
- molecule according
- fab
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17306337.1 | 2017-10-05 | ||
| EP17306337.1A EP3466975A1 (en) | 2017-10-05 | 2017-10-05 | A specific binding molecule directed against galectin-3 protein |
| PCT/EP2018/077131 WO2019068863A1 (en) | 2017-10-05 | 2018-10-05 | SPECIFIC BINDING MOLECULE DIRECTED AGAINST GALECTIN-3 PROTEIN |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021500874A JP2021500874A (ja) | 2021-01-14 |
| JP2021500874A5 true JP2021500874A5 (enExample) | 2021-10-28 |
| JP7325407B2 JP7325407B2 (ja) | 2023-08-14 |
Family
ID=60119974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020519382A Active JP7325407B2 (ja) | 2017-10-05 | 2018-10-05 | ガレクチン－３タンパク質に対する特異的結合分子 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US11091552B2 (enExample) |
| EP (2) | EP3466975A1 (enExample) |
| JP (1) | JP7325407B2 (enExample) |
| WO (1) | WO2019068863A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018308088B2 (en) | 2017-07-25 | 2025-05-29 | Truebinding, Inc. | Treating cancer by blocking the interaction of TIM-3 and its ligand |
| US12180285B2 (en) | 2018-02-01 | 2024-12-31 | Memorial Sloan Kettering Cancer Center | Antibodies to galectin-3 and methods of use thereof |
| JP2022523333A (ja) | 2019-01-30 | 2022-04-22 | トゥルーバインディング，インコーポレイテッド | 抗ｇａｌ３抗体およびその使用 |
| US12281166B2 (en) * | 2020-05-26 | 2025-04-22 | Truebinding, Inc. | Methods of treating inflammatory diseases by blocking Galectin-3 |
| EP4259201A4 (en) * | 2020-12-08 | 2025-03-19 | Memorial Sloan Kettering Cancer Center | Antibodies to galectin-3 and methods of use thereof |
| CN115746134A (zh) * | 2021-10-15 | 2023-03-07 | 深圳市睿盟创新生物科技有限公司 | 半乳糖凝集素-3的免疫测定 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2874751B2 (ja) | 1986-04-09 | 1999-03-24 | ジェンザイム・コーポレーション | 希望する蛋白質をミルク中へ分泌する遺伝子移植動物 |
| US20090318308A1 (en) | 2006-05-30 | 2009-12-24 | Millegen | Highly diversified antibody libraries |
| WO2008112559A1 (en) * | 2007-03-09 | 2008-09-18 | Regents Of The University Of California | Suppression of galectin-3 for treating an inflammatory condition |
| FR2919062B1 (fr) * | 2007-07-19 | 2009-10-02 | Biomerieux Sa | Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal. |
| CA2742265C (en) * | 2008-10-29 | 2014-07-15 | Bg Medicine, Inc. | Galectin-3 immunoassay |
| US20170014446A1 (en) * | 2014-03-10 | 2017-01-19 | La Jolla Pharmaceutical Company | Compositions and methods for administering galectin antagonists |
| WO2016004093A2 (en) * | 2014-07-01 | 2016-01-07 | Stealth Biotherapeutics Corp | Therapeutic compositions including galectin-3 inhibitors and uses thereof |
-
2017
- 2017-10-05 EP EP17306337.1A patent/EP3466975A1/en not_active Withdrawn
-
2018
- 2018-10-05 EP EP18782448.7A patent/EP3692067A1/en active Pending
- 2018-10-05 JP JP2020519382A patent/JP7325407B2/ja active Active
- 2018-10-05 US US16/753,671 patent/US11091552B2/en active Active
- 2018-10-05 WO PCT/EP2018/077131 patent/WO2019068863A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021500874A5 (enExample) | ||
| JP2018504907A5 (enExample) | ||
| JP2017176174A5 (enExample) | ||
| JP2013539454A5 (enExample) | ||
| JP2019535763A5 (enExample) | ||
| JP2016529229A5 (enExample) | ||
| CN111989346A (zh) | 结合cd47蛋白的融合蛋白及其应用 | |
| CN115551888A (zh) | 抗cd73抗体及其用途 | |
| JP2020501532A5 (enExample) | ||
| JP2017048194A5 (enExample) | ||
| JP2018537399A5 (enExample) | ||
| WO2018089508A3 (en) | Anti-cd47 antibodies | |
| PE20181336A1 (es) | Anticuerpos que se unen a interleucina 8 (il-8) y sus usos | |
| NL300919I2 (nl) | Brodalumab | |
| MA43024B1 (fr) | Anticorps humanisés cd19 antihumains et procédés d'utilisation | |
| EA201991099A1 (ru) | Антитела против cd73 и их применение | |
| EA201892362A1 (ru) | Агонистические антитела, которые связываются с cd40 человека, и варианты их применения | |
| WO2017193032A3 (en) | Bispecific binding proteins and uses thereof | |
| JP2016063812A5 (enExample) | ||
| JP2017113019A5 (enExample) | ||
| PE20071055A1 (es) | Anticuerpos anti mn | |
| PE20181270A1 (es) | Anticuerpo que neutraliza el virus respiratorio sincitial humano | |
| EA201291243A1 (ru) | Антитела против респираторно-синцитиального вируса (рсв) и способы их применения | |
| JP2015527366A5 (enExample) | ||
| CN109415770A (zh) | 乳腺癌标志物及应用 |